Optimizations of SiRNA Design for the Activation of Gene Transcription by Targeting the TATA-Box Motif
暂无分享,去创建一个
[1] Emmanuel C. Alozie,et al. Promises and Challenges , 2015 .
[2] G. Geng,et al. A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region , 2014, Retrovirology.
[3] C. Rice,et al. MX2 is an interferon-induced inhibitor of HIV-1 infection , 2013, Nature.
[4] J. Doudna,et al. Molecular mechanisms of RNA interference. , 2013, Annual review of biophysics.
[5] J. Engels. Gene silencing by chemically modified siRNAs. , 2013, New biotechnology.
[6] Giovanna Ambrosini,et al. EPD and EPDnew, high-quality promoter resources in the next-generation sequencing era , 2012, Nucleic Acids Res..
[7] Jing Liu,et al. Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression , 2012, Cell.
[8] Stanley T. Crooke,et al. Single-Stranded siRNAs Activate RNAi in Animals , 2012, Cell.
[9] R. Place,et al. Upregulation of Cyclin B1 by miRNA and its implications in cancer , 2011, Nucleic acids research.
[10] D. Cooper,et al. Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific , 2011, RNA biology.
[11] D. Perkins,et al. Nuclear and cytoplasmic localization of neural stem cell microRNAs. , 2011, RNA.
[12] Scott T. Younger,et al. Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters , 2011, Nucleic acids research.
[13] Yongjun Chu,et al. Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter , 2010, Nucleic acids research.
[14] Hui Zhou,et al. Deep Sequencing of Human Nuclear and Cytoplasmic Small RNAs Reveals an Unexpectedly Complex Subcellular Distribution of miRNAs and tRNA 3′ Trailers , 2010, PloS one.
[15] G. Stoecklin,et al. On track with P-bodies. , 2010, Biochemical Society transactions.
[16] A. Goodchild,et al. Intended transcriptional silencing with siRNA results in gene repression through sequence-specific off-targeting. , 2010, RNA.
[17] J. Doudna,et al. Structural insights into the human GW182-PABC interaction in microRNA-mediated deadenylation , 2010, Nature Structural &Molecular Biology.
[18] F. Holstege,et al. Distinct promoter dynamics of the basal transcription factor TBP across the yeast genome , 2009, Nature Structural &Molecular Biology.
[19] D. Cooper,et al. Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription. , 2009, Microbes and infection.
[20] J. Kjems,et al. A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity , 2009, Nucleic acids research.
[21] V. Patzel,et al. siRNA stabilization prolongs gene knockdown in primary T lymphocytes , 2008, European journal of immunology.
[22] D. Corey,et al. Antisense transcripts are targets for activating small RNAs , 2008, Nature Structural &Molecular Biology.
[23] J. T. Kadonaga,et al. The RNA polymerase II core promoter - the gateway to transcription. , 2008, Current opinion in cell biology.
[24] A. F. Bochner,et al. An Argonaute Transports siRNAs from the Cytoplasm to the Nucleus , 2008, Science.
[25] K. Ui-Tei,et al. Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect , 2008, Nucleic acids research.
[26] R. Place,et al. MicroRNA-373 induces expression of genes with complementary promoter sequences , 2008, Proceedings of the National Academy of Sciences.
[27] David R Corey,et al. Chemical modification: the key to clinical application of RNA interference? , 2007, The Journal of clinical investigation.
[28] Boris Lenhard,et al. Mammalian RNA polymerase II core promoters: insights from genome-wide studies , 2007, Nature Reviews Genetics.
[29] D. Corey,et al. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. , 2007, Nature chemical biology.
[30] E. Wentzel,et al. A Hexanucleotide Element Directs MicroRNA Nuclear Import , 2007, Science.
[31] Anthony D. Keefe,et al. Building oligonucleotide therapeutics using non-natural chemistries. , 2006, Current opinion in chemical biology.
[32] R. Place,et al. Small dsRNAs induce transcriptional activation in human cells , 2006, Proceedings of the National Academy of Sciences.
[33] D. Corey,et al. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing , 2006, Nature Structural &Molecular Biology.
[34] L. Lim,et al. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. , 2006, RNA.
[35] K. Alexander,et al. High potency silencing by single-stranded boranophosphate siRNA , 2006, Nucleic acids research.
[36] Aleksey Y. Ogurtsov,et al. Computational models with thermodynamic and composition features improve siRNA design , 2006, BMC Bioinformatics.
[37] Chinmay Y. Majmudar,et al. Chemical approaches to transcriptional regulation. , 2005, Current opinion in chemical biology.
[38] A. Pasquinelli,et al. Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.
[39] D. Corey,et al. Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs , 2005, Nature chemical biology.
[40] Bernd Jagla,et al. Sequence characteristics of functional siRNAs. , 2005, RNA.
[41] R. Griffey,et al. Positional effect of chemical modifications on short interference RNA activity in mammalian cells. , 2005, Journal of medicinal chemistry.
[42] Sangdun Choi,et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy , 2005, Nature Biotechnology.
[43] R. Griffey,et al. Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. , 2005, Journal of medicinal chemistry.
[44] P. Dervan,et al. Small molecule transcription factor mimic. , 2004, Journal of the American Chemical Society.
[45] Matthias John,et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.
[46] Marion Jurk,et al. Modulation of CpG oligodeoxynucleotide-mediated immune stimulation by locked nucleic acid (LNA). , 2004, Oligonucleotides.
[47] P. Zamore,et al. Kinetic analysis of the RNAi enzyme complex , 2004, Nature Structural &Molecular Biology.
[48] Anton P. McCaffrey,et al. In vivo activity of nuclease-resistant siRNAs. , 2004, RNA.
[49] A. Reynolds,et al. Rational siRNA design for RNA interference , 2004, Nature Biotechnology.
[50] K. Ui-Tei,et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. , 2004, Nucleic acids research.
[51] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[52] T. Du,et al. Asymmetry in the Assembly of the RNAi Enzyme Complex , 2003, Cell.
[53] S. Jayasena,et al. Functional siRNAs and miRNAs Exhibit Strand Bias , 2003, Cell.
[54] Bo Liu,et al. Transcription activation by a PNA-peptide chimera in a mammalian cell extract. , 2003, Chemistry & biology.
[55] T. Rana,et al. siRNA function in RNAi: a chemical modification analysis. , 2003, RNA.
[56] H. Herweijer,et al. Progress and prospects: naked DNA gene transfer and therapy , 2003, Gene Therapy.
[57] M. Amarzguioui,et al. Tolerance for mutations and chemical modifications in a siRNA. , 2003, Nucleic acids research.
[58] A. Ansari,et al. Modular design of artificial transcription factors. , 2002, Current opinion in chemical biology.
[59] M. Ptashne,et al. Design of artificial transcriptional activators with rigid poly-L-proline linkers. , 2002, Journal of the American Chemical Society.
[60] Phillip D Zamore,et al. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. , 2002, Molecular cell.
[61] F. Bushman,et al. Inhibition of Retroviral Pathogenesis by RNA Interference , 2002, Current Biology.
[62] R. Andino,et al. Short interfering RNA confers intracellular antiviral immunity in human cells , 2002, Nature.
[63] J. Lieberman,et al. siRNA-directed inhibition of HIV-1 infection , 2002, Nature Medicine.
[64] Ali Ehsani,et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells , 2002, Nature Biotechnology.
[65] T. Tuschl,et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs. , 2002, Methods.
[66] T. Tuschl,et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate , 2001, The EMBO journal.
[67] P. Zamore,et al. ATP Requirements and Small Interfering RNA Structure in the RNA Interference Pathway , 2001, Cell.
[68] M. Ptashne,et al. Towards a minimal motif for artificial transcriptional activators. , 2001, Chemistry & biology.
[69] T. Tuschl,et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.
[70] S. Hammond,et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells , 2000, Nature.
[71] M. Manoharan. 2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation. , 1999, Biochimica et biophysica acta.
[72] P. D. Cook,et al. Making drugs out of oligonucleotides: a brief review and perspective. , 1999, Nucleosides & nucleotides.
[73] R. Davis,et al. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways , 1996, Journal of Molecular Medicine.
[74] N. Sugimoto,et al. Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. , 1995, Biochemistry.
[75] P. D. Cook,et al. Characterization of fully 2'-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. , 1995, Nucleic acids research.
[76] P. D. Cook,et al. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. , 1993, The Journal of biological chemistry.
[77] A. Baldwin,et al. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation , 1993, Molecular and cellular biology.
[78] A. Murakami,et al. Hybridization arrest of globin synthesis in rabbit reticulocyte lysates and cells by oligodeoxyribonucleoside methylphosphonates. , 1985, Biochemistry.
[79] P. Miller,et al. Oligothymidylate analogues having stereoregular, alternating methylphosphonate/phosphodiester backbones as primers for DNA polymerase. , 1982, Biochemistry.
[80] Will French. Function I , 1937 .
[81] K. Ui-Tei,et al. Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus. , 2013, RNA.
[82] T. Rana,et al. Illuminating the silence: understanding the structure and function of small RNAs , 2007, Nature Reviews Molecular Cell Biology.
[83] B. Reinhart,et al. A biochemical framework for RNA silencing in plants. , 2003, Genes & development.
[84] M. Stevenson,et al. Modulation of HIV-1 replication by RNA interference , 2002, Nature.
[85] Brett,et al. Evaluation of 2”Modified Oligonucleotides Containing 2’-Deoxy Gaps as Antisense Inhibitors of Gene Expression* , 2001 .
[86] Leaf Huang,et al. Nonviral gene therapy: promises and challenges , 2000, Gene Therapy.
[87] H. Pahl,et al. Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[88] T. Mukhopadhyay,et al. Antisense therapy for cancer. , 1995, The cancer journal from Scientific American.